Engineered T Cell Receptors and Methods of Use, University of Texas System, EP4161555A1
Summary
The European Patent Office published application EP4161555A1 titled 'Engineered T Cell Receptors and Methods of Use' on April 15, 2026. The applicants are the Board of Regents, The University of Texas System, with inventors Yee, Cassian and PAN, Ke listed. The patent covers engineered T cell receptors and methods of use, classified under IPC codes including A61K 38/00, C07K 14/725, C07K 19/00, and C12N 15/62. This publication makes the application publicly available and initiates the opposition period in designated European states.
About this source
GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The EPO published patent application EP4161555A1 covering engineered T cell receptors and methods of use, filed by the Board of Regents, The University of Texas System. Inventors include Yee, Cassian and PAN, Ke. The application was published April 15, 2026 and is now publicly available in all designated European states including DE, FR, GB, IT, NL, ES, and 25 others.
Affected parties including biotechnology companies, pharmaceutical developers, and researchers working in immunotherapy should monitor this publication for potential licensing implications or freedom-to-operate considerations. The broad IPC classifications covering medicinal preparations, artificial proteins, hybrid peptides, and genetic engineering suggest the patent could have implications across multiple areas of cellular therapy development.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ENGINEERED T CELL RECEPTORS AND METHODS OF USE
Publication EP4161555A1 Kind: A1 Apr 15, 2026
Applicants
Board of Regents, The University of Texas System
Inventors
YEE, Cassian, PAN, Ke
IPC Classifications
A61K 38/00 20060101AFI20240514BHEP C07K 14/725 20060101ALI20240514BHEP C07K 19/00 20060101ALI20240514BHEP C12N 15/62 20060101ALI20240514BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.